BONE BIOLOGICS CORPORATION
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $4.4M | $5.0M | $5.8M | $6.4M | $7.0M | $3.2M | $3.9M | $4.1M |
| Property, Plant & Equipment | — | — | — | — | — | — | — | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $4.4M | $5.0M | $5.8M | $6.4M | $7.0M | $3.2M | $3.9M | $4.1M |
| Liabilities | ||||||||
| Accounts Payable | — | — | — | — | — | — | — | — |
| Total Current Liabilities | $512.0K | $309.4K | $418.6K | $334.3K | $406.1K | $251.2K | $377.7K | $273.4K |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $512.0K | $309.4K | $418.6K | $334.3K | $406.1K | $251.2K | $377.7K | $273.4K |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-89.7M | $-88.9M | $-88.1M | $-87.4M | $-86.8M | $-86.0M | $-85.0M | $-83.5M |
| Total Stockholders' Equity | $3.9M | $4.7M | $5.4M | $6.0M | $6.6M | $2.9M | $3.5M | $3.8M |